New injection aims to help sleep apnea patients breathe easier and lose weight
NCT ID NCT06994650
Summary
This study is testing whether a new injectable medication called HRS9531 can help people who have both obesity and obstructive sleep apnea. The trial will involve 140 adults who are already using a CPAP machine for their sleep apnea. Researchers will measure if the injection reduces breathing pauses during sleep and helps with weight loss over one year of treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUBJECTS WITH MODERATE-TO-SEVERE OSA AND OBESITY WHO ARE ON PAP THERAPY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Peking University People's Hospital
RECRUITINGBeijing, Beijing Municipality, 100044, China
Contact
Conditions
Explore the condition pages connected to this study.